2026 Biotech IPO Tracker: Deals, Proceeds & Performance

Live tracker of biotech/biopharma IPOs in 2026 — therapeutic area, lead asset + phase at IPO, pricing date, proceeds and valuation, plus aftermarket performance. Updated Weekly.

Biotech M&A Tracker 2026 — Deals, Upfronts + Totals (Updated Weekly)

Live tracker of biotech/biopharma M&A in 2026: target, acquirer, announced date, deal value, upfront, structure, premium, and rationale. Updated weekly.

Biotech BD&L Deal Tracker 2026: Upfronts, Milestones + Royalties

Live tracker of biotech/biopharma licensing + partnering deals in 2026 — upfronts, milestones, royalties, rights/territory, and a one-line “why it matters.” Updated weekly.

Biotech M&A Rumor Tracker 2026 — Reported Talks, Status, Sources (Updated Weekly)

Live tracker of biotech/biopharma rumors in 2026 — target, acquirer, reported deal values, status, updates and sources. Updated Weekly.

Biotech VC Funding Tracker 2026: Deals + Syndicates

Private financings — Company, date, round, investors, therapeutic area, and a one-line “what they do.”